FDA.reportPublic FDA data

ETHINYL ESTRADIOL

Substance profile for UNII 423D2T571U, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for ETHINYL ESTRADIOL
Structure render from PubChem CID 5991

Substance Identity#

UNII
423D2T571U
Preferred term
ETHINYL ESTRADIOL
Registry number
57-63-6
EC number
200-342-2
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C20H24O2
Chemical structure for ETHINYL ESTRADIOL
Structure render from PubChem CID 5991

Chemical And Database Identifiers#

InChIKey
BFPYWIDHMRZLRN-SLHNCBLASA-N
SMILES
C[C@]12CC[C@H]3[C@@H](CCC4=CC(O)=CC=C34)[C@@H]1CC[C@@]2(O)C#C
RxCUI
4124
PubChem
5991
NCIt
C486
INN ID
437

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound5991pubchem.ncbi.nlm.nih.gov/compound/5991
PubChem InChIKey SearchBFPYWIDHMRZLRN-SLHNCBLASA-Npubchem.ncbi.nlm.nih.gov/#query=BFPYWIDHMRZLRN-SLHNCBLASA-N
RxNorm4124mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=4124
NCI ThesaurusC486ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C486
FDA Substance Registration System423D2T571Uprecision.fda.gov/uniisearch/srs/unii/423D2T571U
European Community number200-342-2commonchemistry.cas.org/results?q=200-342-2

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE MOIETYLomedia 24 Fe6
ACTIVE INGREDIENTLomedia 24 Fe6
ACTIVE MOIETYWYMZYA™Fe (norethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets) 0.4 mg/35 mcg1
ACTIVE INGREDIENTWYMZYA™Fe (norethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets) 0.4 mg/35 mcg1
ACTIVE MOIETYFalessa Kit5
ACTIVE INGREDIENTFalessa Kit5
ACTIVE MOIETYDELYLA™ (Levonorgestrel and Ethinyl Estradiol Tablets, USP) Rx only1
ACTIVE INGREDIENTDELYLA™ (Levonorgestrel and Ethinyl Estradiol Tablets, USP) Rx only1
ACTIVE INGREDIENTZenchent FE2
ACTIVE MOIETYZenchent FE2
ACTIVE INGREDIENTPirmella™ 1/35 (norethindrone and ethinyl estradiol tablets USP) 1 mg/0.035 mg Rx Only5
ACTIVE MOIETYPirmella™ 1/35 (norethindrone and ethinyl estradiol tablets USP) 1 mg/0.035 mg Rx Only5
ACTIVE MOIETYWYMZYA TM Fe (norethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets) 0.4 mg/35 mcg1
ACTIVE INGREDIENTWYMZYA TM Fe (norethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets) 0.4 mg/35 mcg1
ACTIVE MOIETYNecon ® 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP) Rx only1
ACTIVE INGREDIENTNecon ® 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP) Rx only1
ACTIVE MOIETYWATSON PHARMA Revised: May 2005 IN-5262/S PHYSICIAN LABELING Levora ® 0.15/30-28 (levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg) Rx only1
ACTIVE INGREDIENTWATSON PHARMA Revised: May 2005 IN-5262/S PHYSICIAN LABELING Levora ® 0.15/30-28 (levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg) Rx only1
ACTIVE MOIETYWATSON PHARMA Revised: May 2005 IN-5262/S PHYSICIAN LABELING Levora ® 0.15/30-28 (levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg) Rx only1
ACTIVE INGREDIENTWATSON PHARMA Revised: May 2005 IN-5262/S PHYSICIAN LABELING Levora ® 0.15/30-28 (levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg) Rx only1
ACTIVE INGREDIENTJunel ® 21 Day (norethindrone acetate and ethinyl estradiol tablets, USP) Junel ® Fe 28 Day (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay.1
ACTIVE MOIETYJunel ® 21 Day (norethindrone acetate and ethinyl estradiol tablets, USP) Junel ® Fe 28 Day (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay.1
ACTIVE INGREDIENTNortrel™ 7/7/7 (norethindrone and ethinyl estradiol tablets, USP 0.5/0.035 mg, 0.75/0.035 mg, and 1/0.035 mg)1
ACTIVE MOIETYNortrel™ 7/7/7 (norethindrone and ethinyl estradiol tablets, USP 0.5/0.035 mg, 0.75/0.035 mg, and 1/0.035 mg)1
ACTIVE INGREDIENTTriNessa ® Tablets (norgestimate and ethinyl estradiol)1
ACTIVE MOIETYTriNessa ® Tablets (norgestimate and ethinyl estradiol)1
ACTIVE INGREDIENTVelivet ™ (desogestrel and ethinyl estradiol tablets, USP - triphasic regimen) Rx only PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES.2
ACTIVE MOIETYVelivet ™ (desogestrel and ethinyl estradiol tablets, USP - triphasic regimen) Rx only PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES.2
ACTIVE INGREDIENTWATSONPHARMA Revised: April 2007 IN-5351/S Lutera® (Levonorgestrel and Ethinyl Estradiol Tablets USP) Rx only1
ACTIVE MOIETYWATSONPHARMA Revised: April 2007 IN-5351/S Lutera® (Levonorgestrel and Ethinyl Estradiol Tablets USP) Rx only1
ACTIVE INGREDIENTMICROGESTIN ® 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP) MICROGESTIN ® Fe 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay. MICROGESTIN ® 1.5/30 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP) MICROGESTIN ® Fe 1.5/30 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay. Rx o1
ACTIVE MOIETYMICROGESTIN ® 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP) MICROGESTIN ® Fe 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay. MICROGESTIN ® 1.5/30 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP) MICROGESTIN ® Fe 1.5/30 (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay. Rx o1
ACTIVE MOIETYTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
ACTIVE INGREDIENTTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
ACTIVE MOIETYJunel ® 21 Day (norethindrone acetate and ethinyl estradiol tablets, USP) Junel ® Fe 28 Day (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay.3
ACTIVE INGREDIENTJunel ® 21 Day (norethindrone acetate and ethinyl estradiol tablets, USP) Junel ® Fe 28 Day (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay.3
ACTIVE INGREDIENTNorgestimate and Ethinyl Estradiol Tablets USP, 0.25 mg/0.035 mg5
ACTIVE MOIETYNorgestimate and Ethinyl Estradiol Tablets USP, 0.25 mg/0.035 mg5
ACTIVE INGREDIENTZovia 1/35E-28 Zovia 1/50E-28 (Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP) Revised: August 2006 Rx only1
ACTIVE INGREDIENTThese highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 20012
ACTIVE MOIETYThese highlights do not include all the information needed to use YASMIN safely and effectively. See full prescribing information for YASMIN. YASMIN (drospirenone/ ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 20012
ACTIVE MOIETYThese highlights do not include all the information needed to use YAZ safely and effectively. See full prescribing information for YAZ. Initial U.S. Approval: 20012
ACTIVE INGREDIENTThese highlights do not include all the information needed to use YAZ safely and effectively. See full prescribing information for YAZ. Initial U.S. Approval: 20012
ACTIVE INGREDIENTORTHO TRI-CYCLEN ® TABLETS ORTHO-CYCLEN ® TABLETS (norgestimate/ethinyl estradiol)2
ACTIVE MOIETYORTHO TRI-CYCLEN ® TABLETS ORTHO-CYCLEN ® TABLETS (norgestimate/ethinyl estradiol)2
ACTIVE INGREDIENT7abf2fff-f612-4842-9d1d-375af93f42591
ACTIVE MOIETYNUVARING ® (etonogestrel/ethinyl estradiol vaginal ring)2
ACTIVE INGREDIENTNUVARING ® (etonogestrel/ethinyl estradiol vaginal ring)2
ACTIVE INGREDIENTThese highlights do not include all the information needed to use LoSeasonique tablets safely and effectively. See full prescribing information for LoSeasonique. LoSeasonique (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) for oral use Initial U.S. Approval: 19822
ACTIVE MOIETYThese highlights do not include all the information needed to use LoSeasonique tablets safely and effectively. See full prescribing information for LoSeasonique. LoSeasonique (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) for oral use Initial U.S. Approval: 19822
ACTIVE INGREDIENTNECON 7/7/7 ® Tablets (norethindrone/ethinyl estradiol)2
ACTIVE MOIETYNECON 7/7/7 ® Tablets (norethindrone/ethinyl estradiol)2
ACTIVE INGREDIENTAviane ® - 28 DAY (levonorgestrel and ethinyl estradiol tablets, USP)1
ACTIVE MOIETYAviane ® - 28 DAY (levonorgestrel and ethinyl estradiol tablets, USP)1
ACTIVE INGREDIENTnorethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets 0.4 mg/35 mcg1
ACTIVE MOIETYnorethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets 0.4 mg/35 mcg1
ACTIVE INGREDIENTRevised: November 2007 IN-5427/S PHYSICIAN LABELING Trivora ® (levonorgestrel and ethinyl estradiol tablets USP) triphasic regimen Rx only1
ACTIVE MOIETYRevised: November 2007 IN-5427/S PHYSICIAN LABELING Trivora ® (levonorgestrel and ethinyl estradiol tablets USP) triphasic regimen Rx only1
ACTIVE INGREDIENTTriNessa ® Tablets (norgestimate and ethinyl estradiol)1
ACTIVE MOIETYTriNessa ® Tablets (norgestimate and ethinyl estradiol)1
ACTIVE INGREDIENTTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
ACTIVE MOIETYTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
ACTIVE INGREDIENTTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
ACTIVE MOIETYTri-Sprintec ® (norgestimate and ethinyl estradiol tablets - triphasic regimen) PATIENTS SHOULD BE COUNSELED THAT THIS PRODUCT DOES NOT PROTECT AGAINST HIV INFECTION (AIDS) AND OTHER SEXUALLY TRANSMITTED DISEASES. Rx only1
ACTIVE MOIETYTilia™ Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay.1
ACTIVE INGREDIENTTilia™ Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay.1
ACTIVE INGREDIENTNecon ® 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP) Rx only1
ACTIVE MOIETYNecon ® 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP) Rx only1
ACTIVE INGREDIENTNecon ® 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP) Rx only1
ACTIVE MOIETYNecon ® 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP) Rx only1
ACTIVE MOIETYOCELLA ™ 28 TABLETS (drospirenone and ethinyl estradiol)2
ACTIVE INGREDIENTOCELLA ™ 28 TABLETS (drospirenone and ethinyl estradiol)2
ACTIVE MOIETYJinteli TM (northindrone acetate and ethinyl estradiol tablets, USP)1
ACTIVE INGREDIENTJinteli TM (northindrone acetate and ethinyl estradiol tablets, USP)1
ACTIVE INGREDIENTORTHO TRI-CYCLEN ® Lo Tablets (norgestimate/ethinyl estradiol)4
ACTIVE MOIETYORTHO TRI-CYCLEN ® Lo Tablets (norgestimate/ethinyl estradiol)4
ACTIVE MOIETY709031e4-4c20-4ea7-beff-6c459709a4331
ACTIVE INGREDIENT709031e4-4c20-4ea7-beff-6c459709a4331
ACTIVE MOIETYENPRESSE™ – 28 TABLETS (levonorgestrel and ethinyl estradiol tablets, USP – triphasic regimen)1
ACTIVE INGREDIENTENPRESSE™ – 28 TABLETS (levonorgestrel and ethinyl estradiol tablets, USP – triphasic regimen)1
ACTIVE MOIETYKelnor™ 1/35 (28 Day Regimen) (ethynodiol diacetate and ethinyl estradiol tablets, USP)2
ACTIVE INGREDIENTKelnor™ 1/35 (28 Day Regimen) (ethynodiol diacetate and ethinyl estradiol tablets, USP)2
ACTIVE MOIETYApri ® (desogestrel and ethinyl estradiol) Tablets1
ACTIVE INGREDIENTApri ® (desogestrel and ethinyl estradiol) Tablets1
ACTIVE INGREDIENTCRYSELLE™ - 28 TABLETS (NORGESTREL AND ETHINYL ESTRADIOL TABLETS, USP)1
ACTIVE MOIETYCRYSELLE™ - 28 TABLETS (NORGESTREL AND ETHINYL ESTRADIOL TABLETS, USP)1
ACTIVE MOIETYSprintec ® (norgestimate and ethinyl estradiol tablets) Rx only1
ACTIVE INGREDIENTSprintec ® (norgestimate and ethinyl estradiol tablets) Rx only1
ACTIVE INGREDIENTKariva ® (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets1
ACTIVE MOIETYKariva ® (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets1
ACTIVE MOIETYENPRESSE™ – 28 TABLETS (levonorgestrel and ethinyl estradiol tablets, USP – triphasic regimen)1
ACTIVE INGREDIENTENPRESSE™ – 28 TABLETS (levonorgestrel and ethinyl estradiol tablets, USP – triphasic regimen)1
ACTIVE INGREDIENTTilia™ Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay.1
ACTIVE MOIETYTilia™ Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets*) *Ferrous fumarate tablets are not USP for dissolution and assay.1
ACTIVE INGREDIENTGianvi TM (drospirenone and ethinyl estradiol) Tablets1
ACTIVE MOIETYGianvi TM (drospirenone and ethinyl estradiol) Tablets1
ACTIVE INGREDIENTZenchent® 0.4/35 (Norethindrone and Ethinyl Estradiol Tablets USP, 0.4 mg/0.035 mg, 28-Day)1
ACTIVE MOIETYZenchent® 0.4/35 (Norethindrone and Ethinyl Estradiol Tablets USP, 0.4 mg/0.035 mg, 28-Day)1
ACTIVE MOIETYGianvi™ (drospirenone and ethinyl estradiol tablets) Rev. D 6/2010 110016851
ACTIVE INGREDIENTGianvi™ (drospirenone and ethinyl estradiol tablets) Rev. D 6/2010 110016851
ACTIVE MOIETYThese highlights do not include all the information needed to use Seasonique safely and effectively. See full prescribing information for Seasonique. Seasonique (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) for oral use Initial U.S. Approval: 19821
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Seasonique safely and effectively. See full prescribing information for Seasonique. Seasonique (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) for oral use Initial U.S. Approval: 19821
ACTIVE INGREDIENT4cafa90a-9903-40d0-b8be-6ad78018b4b61
ACTIVE MOIETY4cafa90a-9903-40d0-b8be-6ad78018b4b61
ACTIVE MOIETYAviane ® - 28 DAY (levonorgestrel and ethinyl estradiol tablets, USP)1
ACTIVE INGREDIENTAviane ® - 28 DAY (levonorgestrel and ethinyl estradiol tablets, USP)1
ACTIVE INGREDIENTFEMCON ® Fe (norethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets) 0.4 mg / 35 mcg1
ACTIVE MOIETYFEMCON ® Fe (norethindrone and ethinyl estradiol tablets, chewable and ferrous fumarate tablets) 0.4 mg / 35 mcg1
ACTIVE INGREDIENTCESIA ® (desogestrel/ethinyl estradiol) Tablets1
ACTIVE INGREDIENTfemhrt ® (norethindrone acetate/ethinyl estradiol tablets)1
ACTIVE MOIETYfemhrt ® (norethindrone acetate/ethinyl estradiol tablets)1
ACTIVE INGREDIENTGILDESS 1.5/30 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]18
ACTIVE MOIETYGILDESS 1.5/30 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]18
ACTIVE MOIETYGILDAGIA (NORETHINDRONE AND ETHINYL ESTRADIOL) KIT [QUALITEST PHARMACEUTICALS]17
ACTIVE INGREDIENTGILDAGIA (NORETHINDRONE AND ETHINYL ESTRADIOL) KIT [QUALITEST PHARMACEUTICALS]17
ACTIVE INGREDIENTGILDESS 1/20 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]17
ACTIVE MOIETYGILDESS 1/20 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]17
ACTIVE INGREDIENTTRI PREVIFEM (NORGESTIMATE AND ETHINYL ESTRADIOL) KIT [QUALITEST PHARMACEUTICALS]15
ACTIVE MOIETYTRI PREVIFEM (NORGESTIMATE AND ETHINYL ESTRADIOL) KIT [QUALITEST PHARMACEUTICALS]15
ACTIVE INGREDIENTMYZILRA (LEVONORGESTREL AND ETHINYL ESTRADIOL) KIT [QUALITEST PHARMACEUTICALS]14